Fibroblasts can be directly reprogrammed into cardiomyocytes, endothelial cells or smooth muscle cells. Here we report the reprogramming of mouse tail-tip fibroblasts simultaneously into cells resembling these three cell types using the microRNA mimic miR-208b-3p, ascorbic acid and bone morphogenetic protein 4, as well as the formation of tissue-like structures formed by the directly reprogrammed cells. Implantation of the formed cardiovascular tissue into the infarcted hearts of mice led to the migration of reprogrammed cells to the injured tissue, reducing regional cardiac strain and improving cardiac function. The migrated endothelial cells and smooth muscle cells contributed to vessel formation, and the migrated cardiomyocytes, which initially displayed immature characteristics, became mature over time and formed gap junctions with host cardiomyocytes. Direct reprogramming of somatic cells to make cardiac tissue may aid the development of applications in cell therapy, disease modelling and drug discovery for cardiovascular diseases.
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
The main data supporting the results in this study are available within the paper and its Supplementary Information. The raw and analysed datasets generated during the study are too large to be publicly shared, but they are available for research purposes from the corresponding author on reasonable request. The RNA-seq data are available from the Gene Expression Omnibus under accession GSE96617, and the scRNA-seq data are available under accessions GSE179589, GSM5420997 and GSM5420998. Source data are provided with this paper.
Lin, Z. & Pu, W. T. Strategies for cardiac regeneration and repair. Sci. Transl. Med. 6, 239rv231 (2014).
Song, K. et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 485, 599–604 (2012).
Ieda, M. et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142, 375–386 (2010).
Jayawardena, T. M. et al. MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ. Res. 110, 1465–1473 (2012).
Jayawardena, T. M. et al. MicroRNA induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function. Circ. Res. 116, 418–424 (2015).
Qian, L. et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 485, 593–598 (2012).
Li, Z. et al. Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation 116, I46–I54 (2007).
Zhu, K. et al. Lack of remuscularization following transplantation of human embryonic stem cell-derived cardiovascular progenitor cells in infarcted nonhuman primates. Circ. Res. 122, 958–969 (2018).
Nguyen, P. K., Lan, F., Wang, Y. & Wu, J. C. Imaging: guiding the clinical translation of cardiac stem cell therapy. Circ. Res. 109, 962–979 (2011).
Ban, K. et al. Cell therapy with embryonic stem cell-derived cardiomyocytes encapsulated in injectable nanomatrix gel enhances cell engraftment and promotes cardiac repair. ACS Nano 8, 10815–10825 (2014).
Gao, L. et al. Large cardiac muscle patches engineered from human induced-pluripotent stem cell-derived cardiac cells improve recovery from myocardial infarction in swine. Circulation 137, 1712–1730 (2018).
Jackman, C. P. et al. Engineered cardiac tissue patch maintains structural and electrical properties after epicardial implantation. Biomaterials 159, 48–58 (2018).
Wang, Q. et al. Functional engineered human cardiac patches prepared from nature’s platform improve heart function after acute myocardial infarction. Biomaterials 105, 52–65 (2016).
Ye, L. et al. Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. Cell Stem Cell 15, 750–761 (2014).
Stevens, K. R. et al. Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc. Natl Acad. Sci. USA 106, 16568–16573 (2009).
Liu, N. & Olson, E. N. MicroRNA regulatory networks in cardiovascular development. Dev. Cell 18, 510–525 (2010).
Tirosh-Finkel, L. et al. BMP-mediated inhibition of FGF signaling promotes cardiomyocyte differentiation of anterior heart field progenitors. Development 137, 2989–3000 (2010).
Kishimoto, Y. et al. Ascorbic acid enhances the expression of type 1 and type 4 collagen and SVCT2 in cultured human skin fibroblasts. Biochem. Biophys. Res. Commun. 430, 579–584 (2013).
Cao, N. et al. Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells. Cell Res. 22, 219–236 (2012).
Esteban, M. A. et al. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 6, 71–79 (2010).
Luo, W. et al. Arterialization requires the timely suppression of cell growth. Nature 589, 437–441 (2021).
Zhou, H., Dickson, M. E., Kim, M. S., Bassel-Duby, R. & Olson, E. N. Akt1/protein kinase B enhances transcriptional reprogramming of fibroblasts to functional cardiomyocytes. Proc. Natl Acad. Sci. USA 112, 11864–11869 (2015).
Souders, C. A., Bowers, S. L. & Baudino, T. A. Cardiac fibroblast: the renaissance cell. Circ. Res. 105, 1164–1176 (2009).
Tarbit, E., Singh, I., Peart, J. N. & Rose’Meyer, R. B. Biomarkers for the identification of cardiac fibroblast and myofibroblast cells. Heart Fail. Rev. 24, 1–15 (2019).
Sgouras, D. N. et al. ERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation. EMBO J. 14, 4781–4793 (1995).
Rai, A. et al. Exosomes derived from human primary and metastatic colorectal cancer cells contribute to functional heterogeneity of activated fibroblasts by reprogramming their proteome. Proteomics 19, e1800148 (2019).
Han, B. et al. The role of TGFBI (βig-H3) in gastrointestinal tract tumorigenesis. Mol. Cancer 14, 64 (2015).
Seeliger, H. et al. EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinoma. Mol. Cancer Res. 7, 189–198 (2009).
Crapo, P. M., Gilbert, T. W. & Badylak, S. F. An overview of tissue and whole organ decellularization processes. Biomaterials 32, 3233–3243 (2011).
Shiba, Y. et al. Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts. Nature 538, 388–391 (2016).
Chong, J. J. et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 510, 273–277 (2014).
Hong, T. & Shaw, R. M. Cardiac T-tubule microanatomy and function. Physiol. Rev. 97, 227–252 (2017).
Manfra, O., Frisk, M. & Louch, W. E. Regulation of cardiomyocyte T-tubular structure: opportunities for therapy. Curr. Heart Fail. Rep. 14, 167–178 (2017).
van der Bogt, K. E. et al. Comparison of different adult stem cell types for treatment of myocardial ischemia. Circulation 118, S121–S129 (2008).
Davis, M. E. et al. Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc. Natl Acad. Sci. USA 103, 8155–8160 (2006).
Jayasankar, V. et al. Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure. Circulation 108, II230–II236 (2003).
Lee, S. J. et al. Enhanced therapeutic and long-term dynamic vascularization effects of human pluripotent stem cell-derived endothelial cells encapsulated in a nanomatrix gel. Circulation 136, 1939–1954 (2017).
Cochain, C., Channon, K. M. & Silvestre, J. S. Angiogenesis in the infarcted myocardium. Antioxid. Redox Signal. 18, 1100–1113 (2013).
Coulombe, K. L., Bajpai, V. K., Andreadis, S. T. & Murry, C. E. Heart regeneration with engineered myocardial tissue. Annu. Rev. Biomed. Eng. 16, 1–28 (2014).
van Mil, A. et al. MicroRNA-1 enhances the angiogenic differentiation of human cardiomyocyte progenitor cells. J. Mol. Med. 91, 1001–1012 (2013).
Shyu, K. G., Wang, B. W., Wu, G. J., Lin, C. M. & Chang, H. Mechanical stretch via transforming growth factor-β1 activates microRNA208a to regulate endoglin expression in cultured rat cardiac myoblasts. Eur. J. Heart Fail 15, 36–45 (2013).
Banerjee, S., Dhara, S. K. & Bacanamwo, M. Endoglin is a novel endothelial cell specification gene. Stem Cell Res. 8, 85–96 (2012).
Laflamme, M. A. et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25, 1015–1024 (2007).
Bai, H. et al. BMP4 regulates vascular progenitor development in human embryonic stem cells through a Smad-dependent pathway. J. Cell. Biochem. 109, 363–374 (2010).
Palojoki, E. et al. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am. J. Physiol. Heart Circ. Physiol. 280, H2726–H2731 (2001).
Giordano, F. J. et al. A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc. Natl Acad. Sci. USA 98, 5780–5785 (2001).
Galow, A. M. et al. Integrative cluster analysis of whole hearts reveals proliferative cardiomyocytes in adult mice. Cells 9, https://doi.org/10.3390/cells9051144 (2020).
Wolfien, M. et al. Single-nucleus sequencing of an entire mammalian heart: cell type composition and velocity. Cells 9, https://doi.org/10.3390/cells9020318 (2020).
Litvinukova, M. et al. Cells of the adult human heart. Nature 588, 466–472 (2020).
Xiao, D. et al. Direct reprogramming of fibroblasts into neural stem cells by single non-neural progenitor transcription factor Ptf1a. Nat. Commun. 9, 2865 (2018).
Treutlein, B. et al. Dissecting direct reprogramming from fibroblast to neuron using single-cell RNA-seq. Nature 534, 391–395 (2016).
Abernathy, D. G. et al. MicroRNAs induce a permissive chromatin environment that enables neuronal subtype-specific reprogramming of adult human fibroblasts. Cell Stem Cell 21, 332–348.e9 (2017).
Kadota, S., Pabon, L., Reinecke, H. & Murry, C. E. In vivo maturation of human induced pluripotent stem cell-derived cardiomyocytes in neonatal and adult rat hearts. Stem Cell Rep. 8, 278–289 (2017).
Cho, G. S. et al. Neonatal transplantation confers maturation of PSC-derived cardiomyocytes conducive to modeling cardiomyopathy. Cell Rep. 18, 571–582 (2017).
Messina, A., Luce, E., Hussein, M. & Dubart-Kupperschmitt, A. Pluripotent-stem-cell-derived hepatic cells: hepatocytes and organoids for liver therapy and regeneration. Cells 9, https://doi.org/10.3390/cells9020420 (2020).
Zamir, L. et al. Nkx2.5 marks angioblasts that contribute to hemogenic endothelium of the endocardium and dorsal aorta. Elife 6, https://doi.org/10.7554/eLife.20994 (2017).
Maddah, M. et al. A non-invasive platform for functional characterization of stem-cell-derived cardiomyocytes with applications in cardiotoxicity testing. Stem Cell Rep. 4, 621–631 (2015).
Alonas, E. et al. Combining single RNA sensitive probes with subdiffraction-limited and live-cell imaging enables the characterization of virus dynamics in cells. ACS Nano 8, 302–315 (2014).
Ban, K. et al. Purification of cardiomyocytes from differentiating pluripotent stem cells using molecular beacons targeting cardiomyocyte-specific mRNA. Circulation, https://doi.org/10.1161/CIRCULATIONAHA.113.004228 (2013).
Trapnell, C., Pachter, L. & Salzberg, S. L. TopHat: discovering splice junctions with RNA-seq. Bioinformatics 25, 1105–1111 (2009).
Anders, S., Pyl, P. T. & Huber, W. HTSeq—a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166–169 (2015).
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).
Dobin, A. & Gingeras, T. R. Mapping RNA-seq reads with STAR. Curr. Protoc. Bioinforma. 51, 11.14.1–11.14.19 (2015).
Vieth, B., Parekh, S., Ziegenhain, C., Enard, W. & Hellmann, I. A systematic evaluation of single cell RNA-seq analysis pipelines. Nat. Commun. 10, 4667 (2019).
Yoon, Y. S. et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J. Clin. Invest. 115, 326–338 (2005).
Yoon, Y. S., Park, J. S., Tkebuchava, T., Luedeman, C. & Losordo, D. W. Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation 109, 3154–3157 (2004).
Kim, S. W., Houge, M., Brown, M., Davis, M. E. & Yoon, Y. S. Cultured human bone marrow-derived CD31+ cells are effective for cardiac and vascular repair through enhanced angiogenic, adhesion, and anti-inflammatory effects. J. Am. Coll. Cardiol. 64, 1681–1694 (2014).
Kim, N. K., Wolfson, D., Fernandez, N., Shin, M. & Cho, H. C. A rat model of complete atrioventricular block recapitulates clinical indices of bradycardia and provides a platform to test disease-modifying therapies. Sci. Rep. 9, 6930 (2019).
We thank J. V. Taylor for sample preparations for TEM images and J. Mobley at the University of Alabama at Birmingham Comprehensive Cancer Center Mass Spectrometry/Proteomics Shared Facility for LC–MS analysis. This work was supported by grants from the National Heart, Lung, and Blood Institute (R01HL150877, R61HL154116, R01HL129511 and R01HL125391), an American Heart Association Transformative Project Award and the Bio and Medical Technology Development Program of the National Research Foundation grant funded by the Korean government (MSIT) (2020M3A9I4038454, 2020R1A2C3003784 and 2017R1D1A1B03036063).
The authors declare no competing interests.
Peer review information Nature Biomedical Engineering thanks Igor Efimov, Masayuki Yazawa and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
mRNA expression of CM genes after the indicated treatment. Expression in MTTFs was set as 1 and U indicates undetected. Ten independent experiments, each with technical replicates. ***P < 0.001: MAB vs MTTF, AA, BMP4, AA/BMP4 and miR-208b. Statistical analysis was performed using one-way ANOVA with Bonferroni’s multiple comparison test. Data are mean ± SEM.
Extended Data Fig. 2 Transcriptome changes during the reprogramming of fibroblasts in total RNA-seq analysis.
a, 3D PCA plot of fibroblasts (D0), reprogrammed cells (D6 & D10), fetal heart, ECs, SMCs and CMs. b, Relative enrichment of gene signatures for heart, ECs, SMCs and CMs in D6 and D10 reprogrammed cells. Genes are sorted by relative expression to D0 (fibroblasts). The presence of gene signatures is shown by black bars. Normalized enrichment score (NES); statistical significance (FDR). c, Heatmap showing expression of fibroblast markers.
a, Representative electrocardiograms of premature ventricular contractions (PVCs, arrows) in MI mice transplanted with d-rCVT (n = 5) or rCVT (n = 5). Telemetry was implanted at day 2 to lessen the surgical trauma to the acute MI animals at day 0. b-c, Representative electrocardiograms of MI mice transplanted with d-rCVT (b) or rCVT (c) upon programmed electrical stimulation after ECG monitoring for 30 days. VT: ventricular tachycardia.
Supplementary figures and table and video captions.
A primer list for RT–qPCR.
Differentially expressed genes across heart, endothelial cell, SMC and CM.
Gene information of clusters 7, 8 and 9 identified in the scRNA-seq data of reprogrammed cells.
Spontaneous contractions of MTTFs treated with MAB.
Calcium transients of MTTFs treated with MAB.
3D view of a vessel with rEC and rSMC.
About this article
Cite this article
Cho, J., Kim, S., Lee, H. et al. Regeneration of infarcted mouse hearts by cardiovascular tissue formed via the direct reprogramming of mouse fibroblasts. Nat Biomed Eng 5, 880–896 (2021). https://doi.org/10.1038/s41551-021-00783-0